Humana Q3 adjusted loss narrows on Medicaid businesses, revenue slightly beats estimates
Overview
U.S. health insurer's Q3 adjusted revenue slightly beat analyst expectations
Adjusted loss per share for Q3 was better than analyst estimates
Company raised full-year 2026 adjusted EPS guidance
Outlook
Humana raises FY 2026 adjusted EPS guidance to at least $9.50, up from $9.00
Company lifts FY 2026 GAAP EPS guidance to at least $15.09, up from $6.52
Humana expects FY 2026 adjusted EPS to decline year-on-year due to Star Ratings headwind
Result Drivers
CENTERWELL AND MEDICAID EXPANSION - Co said strategic expansion of CenterWell and Medicaid businesses contributed to results
CENTERWELL PATIENT GROWTH - Co reported 30% YTD growth in CenterWell Senior Primary Care patients
MEDICAID MEMBERSHIP - Co said Medicaid membership grew 7% YTD, driven by new integrated Duals programs
Company press release:
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q3 Adjusted Revenue | Slight Beat* | $41.16 bln | $40.89 bln (17 Analysts) |
Q3 Adjusted Loss Per Share | Beat | $0.70 | $1.003 (25 Analysts) |
*Applies to a deviation of less than 1%; not applicable for per-share numbers.
Reuters Recommended Reads
Nov 5 - Oscar Health beats Q3 revenue estimates, raises 2026 outlook
Nov 4 - Health insurers, hospitals rally after sweeping midterm win for Democrats
Nov 4 - Agilon Health Q3 revenue beats estimates, raises FY guidance
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)